Indication

Streptococcal endocarditis

Streptococcal endocarditis is an infective endovascular condition characterized by bacterial infection of the heart's endocardium, most frequently colonizing native or prosthetic heart valves. Read more about Streptococcal endocarditis

109 drugs 57 manufacturers

Advertisement

Drugs that treat it

Common Streptococcal endocarditis therapies.

Showing 19–27 of 109 drugs

VANCOMYCIN HCL

VANCOMYCIN INTRAVENOUS·CLOSTRIDIOIDES DIFFICILE INFECTION·+18
MYLAN INSTITUTI
Filter & compare in the drug finder →Opens the drug finder with Streptococcal endocarditis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Streptococcal endocarditis.

Streptococcal endocarditis is an infective endovascular condition characterized by bacterial infection of the heart's endocardium, most frequently colonizing native or prosthetic heart valves.

It is predominantly caused by viridans group streptococci, *Streptococcus gallolyticus*, or other streptococcal species that enter the bloodstream and adhere to pre-existing endothelial lesions or platelet-fibrin thrombi.

Pathophysiologically, the bacteria proliferate within protected vegetations, prompting local valvular destruction, regurgitation, and intracardiac abscesses, as well as systemic complications such as embolic phenomena and immune-mediated vasculitis.

Patients typically present with a subacute or acute clinical course featuring fever, fatigue, new or changing cardiac murmurs, and potentially life-threatening congestive heart failure.

Personalize your experience

Follow Streptococcal endocarditis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it